Lam Research (LRCX -1.4%) remains lower in spite of its FQ2 beat, likely due to the margin...

|About: Lam Research Corporation (LRCX)|By:, SA News Editor

Lam Research (LRCX -1.4%) remains lower in spite of its FQ2 beat, likely due to the margin issues implied by the difference between its strong FQ3 revenue guidance ($620M-$660M vs. $610M consensus) and ho-hum EPS guidance ($0.39-$0.49  vs.$0.44 consensus). Needham remains bullish (previously), arguing Lam's market share gains matter more than its near-term margin pressures. (transcript)